About this trial
A multicenter, randomized, double-blind, sham-controlled trial to investigate the effects of a single session of intraoperative transcutaneous auricular vagus nerve stimulation (taVNS) on perioperative negative emotions (anxiety and depression), pain, nausea, sleep, and recovery in patients undergoing elective breast cancer surgery.
Eligibility criteria
Qualifiers
Aged ≥18 years. Scheduled for elective breast cancer surgery. ASA physical status I-III. Willing and able to provide informed consent.
Disqualifiers
Preoperative MMSE score < 24; severe communication barriers. History of diagnosed dementia, Parkinson's disease, schizophrenia, bipolar disorder, major depressive disorder, or long-term use of psychotropic drugs.
Trial design
Treatments tested in this trial
- Active taVNS
- Sham taVNS
Treatment groups
Sponsors and collaborators
Chinese PLA General Hospital
Lead sponsor
Beijing Tiantan Hospital
Collaborator
Peking University Shougang Hospital
Collaborator